Relevant bibliographies by topics / Booster Vaccines

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Booster Vaccines'

Author: Grafiati
Published: 5 June 2025
Last updated: 2 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Booster Vaccines.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Booster Vaccines"

1

Turabian, Jose Luis. "Relative and Temporal Efficacy of the First and Second Covid 19 Booster Vaccine (3rd And 4th Dose) to Prevent Symptomatic Infection from December 2021 to October 2023 in a General Medicine Office in Toledo (Spain)." Journal of Health Care and Research 5, no. 1 (2024): 39–48. http://dx.doi.org/10.36502/2024/hcr.6234.

Full text
Abstract:
Background: The effectiveness of COVID-19 vaccines in preventing serious infection and death is established, but their protection against infection is less certain. Additionally, their effectiveness diminishes over time. Furthermore, the evolution of the effectiveness of different booster doses of the vaccine against COVID-19, to prevent symptomatic infection in real life during the pandemic and the subsequent endemic, is not clearly documented. Objective: To compare the effectiveness of the 3rd and 4th vaccine boosters against COVID-19 in preventing symptomatic COVID-19 infection during both
APA, Harvard, Vancouver, ISO, and other styles
2

Handayani, Ety Sari, and Nurul Hidayah. "Heterologous Booster Profiles for Recipeints of CoronaVac Inactivated Primary Vaccine: A Scoping Review." Indonesian Journal of Clinical Pharmacy 12, no. 1 (2024): 68–85. https://doi.org/10.15416/ijcp.2023.12.1.68.

Full text
Abstract:
The administration of booster vaccines has been implemented in a number of countries. Unfortunately, there are limited studies of the immune response after booster to recipient with CoronaVac inactivated primary vaccine. This scoping review aims to determine heterologous booster profiles for recipients of the CoronaVac inactivated primary vaccine. This study obtained data from PubMed, Cochrane Library, Medrxiv, Google Scholar and Grey literature. The inclusion criteria were Sars-Cov-2 article, heterologous boosters and CoronaVac vaccine published from 2020 to 2022, written in English, and in a
APA, Harvard, Vancouver, ISO, and other styles
3

Motta, Matt. "The Correlates & Public Health Consequences of Prospective Vaccine Hesitancy among Individuals Who Received COVID-19 Vaccine Boosters in the U.S." Vaccines 10, no. 11 (2022): 1791. http://dx.doi.org/10.3390/vaccines10111791.

Full text
Abstract:
Supplemental “booster” vaccines may prove vital in combating variant waves of endemic COVID-19. Given relatively low levels of booster vaccine uptake, Americans’ willingness to receive a second booster shot is unclear. In a demographically representative survey of N = 3950 US adults (limited to a “boosted” subsample of N = 1551 who had not yet received a second booster), 49% [95% CI: 47, 51] of Americans report having received an initial booster shot, while just 34% [33, 36] report that they would be “very likely” to do so again. Concerns about missing work to vaccinate (−10%; B = 0.53, p = 0.
APA, Harvard, Vancouver, ISO, and other styles
4

ROMBAOA, MARNIE GERALDINE. "Pediatric COVID-19 Booster Hesitancy Among Mothers: Basis for A Proposed Health Education Program." WORLD EDUCATION CONNECT Multidisciplinary e-Publication IV, no. I (2024): 16. https://doi.org/10.5281/zenodo.10559770.

Full text
Abstract:
As the COVID-19 pandemic continues, and transitions to an endemic stage, booster vaccines play an important role in personal, and public health. Convincing people to take boosters continues to be a key problem.  Despite the availability of clinically tested, and effective COVID-19 booster vaccines, convincing people to accept boosters remains a significant challenge. As of 18 January 2023, only 15.3% of the total population in the United States (U.S.) had received the bivalent COVID-19 booster vaccine. In addition, previous research showed people in many countries, especially in low-incom
APA, Harvard, Vancouver, ISO, and other styles
5

Hurst, Jacklyn R., Maedeh Naghibosadat, Patrick Budowski, et al. "Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice." PLOS ONE 19, no. 12 (2024): e0314061. https://doi.org/10.1371/journal.pone.0314061.

Full text
Abstract:
The emergence of SARS-CoV-2 variants presents challenges to vaccine effectiveness, underlining the necessity for next-generation vaccines with multiple antigens beyond the spike protein. Here, we investigated a multiantigenic booster containing spike and a chimeric construct composed of nucleoprotein (N) and membrane (M) proteins, comparing its efficacy to a spike-only booster against Omicron BA.5 in K18-hACE2 mice. Initially, mice were primed and boosted with Beta (B.1.351) spike-only mRNA, showing strong spike-specific T cell responses and neutralizing antibodies, albeit with limited cross-n
APA, Harvard, Vancouver, ISO, and other styles
6

Kamal, Sanaa M., Moheyeldeen Mohamed Naghib, Moataz Daadour, et al. "The Outcome of BNT162b2, ChAdOx1-Sand mRNA-1273 Vaccines and Two Boosters: A Prospective Longitudinal Real-World Study." Viruses 15, no. 2 (2023): 326. http://dx.doi.org/10.3390/v15020326.

Full text
Abstract:
To date, the effectiveness of COVID-19 vaccines and booster doses has yet to be evaluated in longitudinal head-to-head studies. This single-center longitudinal study assessed the effectiveness of ChAdOx1 nCoV-19, BNT162b2, and mRNA-1273 vaccines and assessed two BNT162b2 boosters in 1550 participants, of whom 26% had comorbidities. In addition, the SARS-CoV-2 antibody dynamics was monitored. A group of 1500 unvaccinated subjects was included as the controls. The study’s endpoint was the development of virologically-proven COVID-19 cases after vaccine completion, while the secondary endpoint wa
APA, Harvard, Vancouver, ISO, and other styles
7

Sirison, Kanchanok, Natthaprang Nittayasoot, Ranida Techasuwanna, Nisachol Cetthakrikul, and Rapeepong Suphanchaimat. "Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance." Tropical Medicine and Infectious Disease 8, no. 2 (2023): 91. http://dx.doi.org/10.3390/tropicalmed8020091.

Full text
Abstract:
The Thai government implemented COVID-19 booster vaccines to prevent morbidity and mortality during the spreading of the Omicron variant. However, little is known about which types of vaccine should be invested in as the booster dose for the Thai population. This study aims to investigate the most cost-effective COVID-19 vaccine for a booster shot as empirical evidence for Thai policymakers. This study applied a stochastic simulation based on a compartmental susceptible-exposed-infectious-recovered model and included system dynamics in the model. We evaluated three scenarios: (1) No booster, (
APA, Harvard, Vancouver, ISO, and other styles
8

Lounis, Mohamed, Djihad Bencherit, Mohammed Amir Rais, and Abanoub Riad. "COVID-19 Vaccine Booster Hesitancy (VBH) and Its Drivers in Algeria: National Cross-Sectional Survey-Based Study." Vaccines 10, no. 4 (2022): 621. http://dx.doi.org/10.3390/vaccines10040621.

Full text
Abstract:
Due to the emergence of various highly contagious variants of SARS-CoV-2, vaccine boosters were adopted as a complementary strategy in different countries. This strategy has, however, posed another challenge for the national authorities to convince their population to receive the booster after the first challenge of COVID-19 primer dose vaccines. This study was conducted to determine COVID-19 vaccine booster acceptance and its associated factors in the general population in Algeria. Using social media platforms, an online self-administered questionnaire was distributed between 28 January and 5
APA, Harvard, Vancouver, ISO, and other styles
9

Lin, Zhi-Qiang, Jiang-Nan Wu, Rong-Dong Huang, et al. "Comparison of Safety of Different Vaccine Boosters Following Two-Dose Inactivated Vaccines: A Parallel Controlled Prospective Study." Vaccines 10, no. 4 (2022): 622. http://dx.doi.org/10.3390/vaccines10040622.

Full text
Abstract:
A vaccine booster to maintain high antibody levels and provide effective protection against COVID-19 has been recommended. However, little is known about the safety of a booster for different vaccines. We conducted a parallel controlled prospective study to compare the safety of a booster usingfour common vaccines in China. In total, 320 eligible participants who had received two doses of an inactivated vaccine were equally allocated to receive a booster of the same vaccine (Group A), a different inactivated vaccine (Group B), an adenovirus type-5 vectored vaccine (Group C), or a protein subun
APA, Harvard, Vancouver, ISO, and other styles
10

Limbu, Yam B., and Bruce A. Huhmann. "Why Some People Are Hesitant to Receive COVID-19 Boosters: A Systematic Review." Tropical Medicine and Infectious Disease 8, no. 3 (2023): 159. http://dx.doi.org/10.3390/tropicalmed8030159.

Full text
Abstract:
As the COVID-19 pandemic continues and transitions to an endemic stage, booster vaccines will play an important role in personal and public health. However, convincing people to take boosters continues to be a key obstacle. This study systematically analyzed research that examined the predictors of COVID-19 booster vaccine hesitancy. A search of PubMed, Medline, CINAHL, Web of Science, and Scopus uncovered 42 eligible studies. Globally, the average COVID-19 booster vaccination hesitancy rate was 30.72%. Thirteen key factors influencing booster hesitancy emerged from the literature: demographic
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Booster Vaccines"

1

Filgueira, Fabiana Ariston. "Estudo de títulos protetores para o vírus de hepatite B após esquema vacinal de três doses e \"booster\" em crianças com HIV." Universidade de São Paulo, 2008. http://www.teses.usp.br/teses/disponiveis/5/5141/tde-24112008-103206/.

Full text
Abstract:
INTRODUÇÃO: A hepatite B é uma enfermidade para a qual não existe tratamento curativo efetivo e que pode determinar graves conseqüências, como o desenvolvimento de cirrose e carcinoma hepático. Segundo dados da OMS, mais de dois bilhões de pessoas estão infectadas pelo vírus da hepatite B e esta doença é responsável por 500.000 a um milhão de óbitos por ano, em todo o mundo. Em pacientes com infecção pelo HIV, é freqüente a co-infecção pelo vírus da hepatite B, pelo fato de serem vírus que compartilham modos semelhantes de transmissão. Em vista dessa problemática, a adequada imunização dos pac
APA, Harvard, Vancouver, ISO, and other styles
2

Humby, Samantha A. "An investigation of the effects of helminth worm infection on the capacity of HIV vaccines to boost vaccine-generated immune responses." Master's thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/24896.

Full text
Abstract:
To protect against sexual transmission, successful future HIV vaccines will likely be given to adolescents as a booster subsequent to primary immunization during infancy. In sub-Saharan Africa (SSA), a large proportion of children are chronically infected with a variety of helminths. These infections may suppress the ability of a host to elicit vaccine-induced Th1 responses that are considered important for a successful HIV vaccine. This study investigated the effect of chronic helminthic infection on the boosting capacity of a poxvirus-protein HIV vaccine regimen (SAAVI MVA-C and Env gp140 pr
APA, Harvard, Vancouver, ISO, and other styles
3

Rodriguez, Pozo Andre. "Deep characterization of the Modified Vaccinia Ankara vaccine induced B cell response in the context of prime-boost immunization." Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS061.

Full text
Abstract:
Les anticorps sont des corrélats de protection pour différents vaccins qui sont sur le marché. Une meilleure connaissance des modes d’action des vaccins au cours de la primo-vaccination et des rappels sont nécessaires pour améliorer ceux déjà disponibles et ceux en cours de développement.En développant un pipeline d’analyse des données de cytométrie en masse, nous avons étudié l’hétérogénéité des cellules B de macaques et établi un atlas des cellules B dans diffèrent organes.Nous avons démontré que les cellules B du sang sont enrichies au cours du temps après la primo vaccination et/ou le rapp
APA, Harvard, Vancouver, ISO, and other styles
4

Bråve, Andreas. "Prime-boost immunization strategies against HIV-1 /." Stockholm : Karolinska institutet, 2007. http://diss.kib.ki.se/2007/978-91-7357-327-6/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Badamchi-Zadeh, Alexander. "Heterologous prime-boost vaccine regimens against Chlamydia trachomatis." Thesis, Imperial College London, 2014. http://hdl.handle.net/10044/1/25021.

Full text
Abstract:
Chlamydia trachomatis is the most common bacterial sexually transmitted disease in man and despite decades of effort, there is still no protective vaccine. Left untreated, genital infection can lead to pelvic inflammatory disease, ectopic pregnancy, and infertility. However, infection-induced immunity in both animal models and humans indicates a strong role for CD4+ Th1-biased immune responses. Using a multi-component vaccine approach we assessed the immunogenicity and protective efficacy of novel plasmid DNA, Adenovirus 5 (HuAd5) and modified vaccinia Ankara (MVA) vectors each containing a ma
APA, Harvard, Vancouver, ISO, and other styles
6

Lange, Uta Gisela. "Heterologous prime-boost strategies in the development of novel vaccines against leishmaniasis." Thesis, University of Cambridge, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.619876.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Vaine, Michael. "Antibody Responses Elicited by DNA Prime-Protein Boost HIV Vaccines: A Dissertation." eScholarship@UMMS, 2010. https://escholarship.umassmed.edu/gsbs_diss/462.

Full text
Abstract:
The best known correlate of protection provided by vaccines is the presence of pathogen specific antibodies after immunization. However, against the Human Immunodeficiency Virus-1 (HIV-1) the mere presence of antibodies specific for the viral Envelope (Env) protein is not sufficient to provide protection. This necessitates in depth study of the humoral responses elicited during infection and by vaccination. While a significant amount of effort has been invested in studying the evolution of antibody responses to viral infection, only limited progress in understanding antibody responses elicited
APA, Harvard, Vancouver, ISO, and other styles
8

Biswas, Sumi. "Prime boost vaccination with viral vectors targeting apical membrane antigen 1." Thesis, University of Oxford, 2013. http://ora.ox.ac.uk/objects/uuid:a17ab4e4-9b81-4ab3-b02f-41d9da36c6ab.

Full text
Abstract:
Apical membrane antigen 1 (AMA1) is a leading candidate vaccine antigen against blood stage malaria and several clinical trials using mostly protein-in-adjuvant vaccines have shown limited success. This thesis describes the development of recombinant adenoviral (AdHu5) and poxviral (MVA) vectors encoding AMA1 from Plasmodium chabaudi murine parasites. In this murine malaria model, AdHu5 and MVA encoding AMA1 when used in a heterologous prime boost regime showed excellent immunogenicity, both humoral and cellular. The vaccination regime was protective against blood stage challenge and both anti
APA, Harvard, Vancouver, ISO, and other styles
9

Bernelin-Cottet, Cindy. "Développement d'un vaccin à ADN contre le virus du Syndrome Dysgénésique et Respiratoire Porcin (PRRSV)." Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLA004/document.

Full text
Abstract:
Le Syndrome Dysgénésique et Respiratoire Porcin (PRRS) est la maladie infectieuse endémique la plus couteuse en élevage porcin dont l'agent responsable est un Arterivirus, le PRRSV, qui présente une grande diversité génétique. L'infection par le PRRSV est fréquemment associée à l'infection par les virus influenza. La vaccination est une méthode de lutte adaptée contre ces virus. Dans le cas du PRRSV, les vaccins les plus utilisés sont des virus vivants modifiés (MLV) qui induisent une immunité protectrice peu efficace contre les variants viraux. Dans le cas du virus influenza, les vaccins inac
APA, Harvard, Vancouver, ISO, and other styles
10

Buglione-Corbett, Rachel. "Adjuvant-Specific Serum Cytokine Profiles in the Context of a DNA Prime-Protein Boost HIV-1 Vaccine: A Dissertation." eScholarship@UMMS, 2013. https://escholarship.umassmed.edu/gsbs_diss/666.

Full text
Abstract:
In recent years, heterologous prime-boost vaccination constructs have emerged as a promising strategy to generate broad and protective immunity against a variety of pathogens. The utility of DNA vaccination in priming the immune system, in particular, has improved the immunogenicity of vaccines against difficult pathogens such as HIV-1. In addition, many vaccine formulations include an adjuvant to augment immune responses. However, the mechanisms and profiles of many adjuvants remain largely unknown, particularly in the context of such combination immunization approaches. My thesis research st
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Booster Vaccines"

1

Heijstek, Marloes, Mario Abinun, and Nico Wulffraat. Vaccination in immunocompromised children. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0095.

Full text
Abstract:
Can immunocompromised children be safely and effectively vaccinated? This chapter discusses the recommendations from the European League Against Rheumatism (EULAR) for the immunization of immunocompromised patients. Patients with rheumatic or autoinflammatory diseases treated with high-dose glucocorticoids, high-dose disease-modifying anti-rheumatic drugs (DMARDs), or biologicals are considered immunocompromised. Safe and effective vaccination is crucial in these patients, given their increased risk of infection. Safe vaccination implies that vaccination has no effect on disease activity and h
APA, Harvard, Vancouver, ISO, and other styles
2

Heijstek, Marloes, Mario Abinun, and Nico Wulffraat. Vaccination in immunocompromised children. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0095_update_003.

Full text
Abstract:
Can immunocompromised children be safely and effectively vaccinated? This chapter discusses the recommendations from the European League Against Rheumatism (EULAR) for the immunization of immunocompromised patients. Patients with rheumatic or autoinflammatory diseases treated with high-dose glucocorticoids, high-dose disease-modifying antirheumatic drugs (DMARDs), or biologicals are considered immunocompromised. Safe and effective vaccination is crucial in these patients, given their increased risk of infection. Safe vaccination implies that vaccination has no effect on disease activity and ha
APA, Harvard, Vancouver, ISO, and other styles
3

Suarez, Bryan. Q3 of Covid-19: Truths about Covid-19 Vaccines, Delta Variant, Booster Doses, Immunity, Breakthrough and Coronavirus Scam. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Smith, Mary. Moderna Vaccine: COVID Vaccine Booster Improving the Health Sector. Independently Published, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

TOWNS, Shantell. Don't Worry I've Had Both My Shots and Booster Vaccine Jounal 6x9 Inch. Independently Published, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

LINDA. Don T Worry I Ve Had Both My Shots and Booster Funny Vaccine V-Neck. Independently Published, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Publishing, Qwerty Designs. Funny July 4th Shots and Booster Vaccine American Flag: 6x9 Notes, Diary, Journal 110 Page. Independently Published, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Publishing, Qwerty Designs. Don't Worry I've Had Both My Shots and Booster Funny Vaccine: 6x9 Notes, Diary, Journal 110 Page. Independently Published, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Identifying Strategies to Boost COVID-19 Vaccine Acceptance in the United States. RAND Corporation, 2021. http://dx.doi.org/10.7249/rra1446-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Horton, Richard. Don't Worry I've Had Both My Shots and Booster Funny Vaccine College Ruled Line - 130 Pages - 8. 5 X 11 In. Independently Published, 2022.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Booster Vaccines"

1

Morrison, Hazel, and Helen McShane. "BCG: Past, Present and Future Direction." In Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-24355-4_8.

Full text
Abstract:
AbstractBacillus Calmette-Guérin (BCG) is a live-attenuated vaccine developed over 100 years ago and remains the only vaccine ever licensed in the fight against tuberculosis (TB). It is one of the most widely used vaccines in the world, having been administered to over four billion people, with another 100 million children vaccinated with BCG every year. Despite this, significant debate exists surrounding its efficacy against TB and its place in routine infant vaccination schedules. Severe side effects following BCG administration are rare but may be seen in those with immune system dysfunctio
APA, Harvard, Vancouver, ISO, and other styles
2

Kristian, Yohan, Adira Valdi Yesenia, Safina Safina, Anindya Apriliyanti Pravitasari, Eka Novita Sari, and Tutut Herawan. "Social Media Text Analysis on Public’s Sentiments of Covid-19 Booster Vaccines." In Computational Science and Its Applications – ICCSA 2023 Workshops. Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-37105-9_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jain, Ananya, and Shilpa Sharma. "Nanotechnology in COVID-19 Vaccines." In Proceedings of the Conference BioSangam 2022: Emerging Trends in Biotechnology (BIOSANGAM 2022). Atlantis Press International BV, 2022. http://dx.doi.org/10.2991/978-94-6463-020-6_3.

Full text
Abstract:
AbstractNanotechnology has been proposed in vaccine development as carriers and adjuvants time and again but received limited recognition before the development of vaccines for the COVID-19 pandemic. Nanotechnology has played a pivotal role in the triumph of the vaccines for the current pandemic caused by the SARS-CoV-2 virus. The first vaccine got approved within a year of the earliest reported case of the novel coronavirus. Presently, more than 35 vaccines are approved in at least one country, 10 out of which are sanctioned for emergency use by the WHO. The key categories include peptide vac
APA, Harvard, Vancouver, ISO, and other styles
4

Wijesundara, Danushka K., and Charani Ranasinghe. "Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines." In Gene Vaccines. Springer Vienna, 2011. http://dx.doi.org/10.1007/978-3-7091-0439-2_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Palmowski, Michael J., and Caroline Smith. "Heterologous Prime-Boost Vaccination in Tumor Immunotherapy." In Handbook of Cancer Vaccines. Humana Press, 2004. http://dx.doi.org/10.1007/978-1-59259-680-5_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Whitlow, Emma, Abu Salim Mustafa, and Shumaila Nida Muhammad Hanif. "Progress in the Development of New Vaccines Against Tuberculosis." In Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-24355-4_10.

Full text
Abstract:
AbstractDue to the shortcomings of currently available BCG vaccines, new strategies have been considered for the development of alternative vaccines against tuberculosis. Many candidate vaccines are in the pipeline with an aim to replace BCG or boost the effect of BCG for prophylaxis. In addition, therapeutic applications are also considered. In this chapter, the current advances and approaches are explored to develop pre- and postexposure vaccines for tuberculosis.
APA, Harvard, Vancouver, ISO, and other styles
7

Yuan, Lijuan. "Prime-Boost Rotavirus Vaccine Regimens Are Highly Effective." In Vaccine Efficacy Evaluation. CRC Press, 2022. http://dx.doi.org/10.1201/b22816-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shah, Nita H., and Moksha H. Satia. "Effectiveness of a Booster Dose of COVID-19 Vaccine." In Mathematical and Computational Modelling of Covid-19 Transmission. River Publishers, 2023. http://dx.doi.org/10.1201/9781032623146-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Khan, Amir S., Kate E. Broderick, and Niranjan Y. Sardesai. "Clinical Development of Intramuscular Electroporation: Providing a “Boost” for DNA Vaccines." In Methods in Molecular Biology. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-9632-8_25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Leangaramgul, P., S. Sapsutthipas, K. Balachandra, K. Matsuo, T. Hamano, and M. Honda. "The immune responses of the prime-boost regimen with rBCG-E12 and rDIs-E12 candidate vaccine." In Animal Cell Technology: Basic & Applied Aspects. Springer Netherlands, 2006. http://dx.doi.org/10.1007/1-4020-4457-7_35.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Booster Vaccines"

1

Baranyi, René, Mustafa Isikoglu, Christoph Aigner, Dominik Hoelbling, and Thomas Grechenig. "Leveraging Serious Game Mechanics to Boost Vaccine Literacy: Insights and Outcomes." In 2024 IEEE International Conference on E-health Networking, Application & Services (HealthCom). IEEE, 2024. https://doi.org/10.1109/healthcom60970.2024.10880839.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lima, Gabrielle, Amanda Portilho, and Elizabeth Gaspari. "Second-generation Vaccines: Adjuvants and Booster Doses." In International Symposium on Immunobiologicals. Instituto de Tecnologia em Imunobiológicos, 2022. http://dx.doi.org/10.35259/isi.2022_52154.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Vouturi, Chrysovalantis. "Mathematical modeling of booster vaccine efficacy for SARS-CoV-2 in healthy,cancer, and immunosuppressed patients." In International Symposium on Infectious Diseases and Vaccines. United Research Forum, 2024. https://doi.org/10.51219/urforum.2024.chrysovalantis-vouturi.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Šaponjić, Vladan. "Association of vaccination status with hospitalization and death outcomes in notified cases of COVID-19." In Proceedings of the International Congress Public Health - Achievements and Challenges. Institute of Public Health of Serbia "Dr Milan Jovanović Batut", 2024. http://dx.doi.org/10.5937/batutphco24041s.

Full text
Abstract:
Background: Serbia provided five different COVID-19 vaccines for all population and foreign citizens residing temporarily in Serbia, including the updated bivalent vaccines. More than 56% of adult population was vaccinated, while 1/3 of population received a booster dose of the vaccine. According to law, cases of COVID-19 must be notified to the Public Health Service information system as of 1 January 2022. Aim: The aim of this study was to analyze association between reported vaccination status and hospitalization and death outcomes in notified cases of COVID-19 in Serbia. Methods: We have re
APA, Harvard, Vancouver, ISO, and other styles
5

Chieh Chen, Yu, Li Yun Wang, Chi Chih Chen, et al. "CD154 ELEVATING CELLULAR IMMUNITY BY UP-REGULATING THE PERCENTAGES OF ANTIGEN-SPECIFIC POSITIVE INTERFERON-GAMMA EXPRESSING CELLS." In Singapore International Conference on Research in Life-Science & Healthcare, 04-05 March 2025. Global Research & Development Services Publishing, 2025. https://doi.org/10.20319/icrlsh.2025.12.

Full text
Abstract:
CD154 plays a central role in the development and regulation of adaptive immune responses in mammals and thus may act as a potential molecular adjuvant due to its enhancement of cytokine expression in immune cells. In this study, CD154-coding sequence was linked with the E2 antigen sequence of the Classical swine fever virus (CSFV) to produce an E2-CD154 vaccine and the specific pathogen free piglets at the age of 4-week old was used as an animal model. The CpG adjuvant, a Toll-like receptor 9 agonist, was used as a positive control. The animals were randomized into three groups and primarily
APA, Harvard, Vancouver, ISO, and other styles
6

Queiroz, Lis Vinhático Pontes, Janaína Seixas Pereira Meirelles, Maria Clara Sales do Nascimento, Thaísa Sobral de Andrade, and Kátia de Miranda Avena. "Meningitis in Brazil and its regions: a reflection on vaccination coverage in the last decade." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.618.

Full text
Abstract:
Introduction: Meningitis is a potentially fatal disease. Vaccines play a fundamental role in its prevention, so it is important to reflect on the vaccination coverage (VC) performed in Brazil and in its regions. Objectives: To analyze the VC of meningitis in Brazil and regions in the last decade. Design and setting: Ecological study carried out in Brazil. Methods: Data were collected in the Information System of the National Immunization Program from the Computer Department of the Unified Health System between 2011 and 2020. The variables analyzed were: region, capitals and immunizers, which a
APA, Harvard, Vancouver, ISO, and other styles
7

"Emergence of SARS-CoV-2 Variant of Concern Omicron: Biological Features and Genomic Concern." In International Conference on Public Health and Humanitarian Action. International Federation of Medical Students' Associations - Jordan, 2022. http://dx.doi.org/10.56950/itrx2370.

Full text
Abstract:
Abstract Corona virus infection is a worldwide health threat that has infected a substantial portion of the world's population and is caused by SARS-CoV-2. It is the natural tendency of a virus to change the genetic makeup through the point mutation, and such viruses are called the variant of the original virus. SARS-CoV-2 virus also undergoes such mutation (may be one or more and distinct from other) over time, and many genetically diverse variant has risen. Such variants might be of variants of concern (VOC) and variant of interest (VOI) based on the differences in virulence, transmissibilit
APA, Harvard, Vancouver, ISO, and other styles
8

Nived, Per, Göran Jönsson, Bo Settergren, et al. "THU0149 PRIME-BOOSTER RESPONSE TO PNEUMOCOCCAL CONJUGATE AND POLYSACCHARIDE VACCINES IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.1125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kumar, Vishnu, Vijay Srinivasan, and Soundar Kumara. "Towards Smart Vaccine Manufacturing: A Preliminary Study During COVID-19." In ASME 2021 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2021. http://dx.doi.org/10.1115/imece2021-70516.

Full text
Abstract:
Abstract Biopharmaceutical community is devising modern techniques to boost the development, production, and distribution of COVID-19 vaccines in large scale with tremendous speed. This has shifted the focus towards smart manufacturing of vaccines through vaccine platforms. Vaccine platforms have great potential to rapidly generate new vaccines and can overcome the challenges of the traditional vaccine manufacturing approach without compromising on safety and efficacy. This preliminary study compares the traditional and modern vaccine manufacturing techniques, reviews COVID-19 vaccine manufact
APA, Harvard, Vancouver, ISO, and other styles
10

Sari, Ayu Novita, Liandhajani, and Diana Laila Ramatillah. "Comparative Evaluation of AEFI (Adverse Event Following Immunization) and Effectiveness of Astrazeneca and Pfizer Booster Vaccines Among Indonesia Citizen." In International Seminar and Call for Paper Universitas 17 Agustus 1945 Jakarta. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0011978400003582.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Booster Vaccines"

1

วรรณลภากร, ณศมน. ผลระยะยาวของการให้วัคซีนไอกรนชนิดเต็มเซลล์ หรือไร้เซลล์ในเด็กทารกที่คลอดจากมารดาที่ได้รับวัคซีนไอกรนขณะตั้งครรภ์. คณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย, 2018. https://doi.org/10.58837/chula.res.2018.26.

Full text
Abstract:
Background: Pertussis vaccination in pregnant women is a strategy currently recommended to foster passive maternal immunity and minimize severe complications from pertussis in not yet completely vaccinated infants. However, the potential interference of maternal antibodies on the development of infant antibody responses induced by childhood whole cell pertussis (wP) and acellular pertussis (aP) vaccination is not well-defined. Methods: This randomized controlled trial (NCT02408926) followed healthy term infants born to tetanus diphtheria acellular pertussis (Tdap)-vaccinated mothers at a terti
APA, Harvard, Vancouver, ISO, and other styles
2

Ripoll, Santiago, Tabitha Hrynick, Ashley Ouvrier, Megan Schmidt-Sane, Federico Marco Federici, and Elizabeth Storer. 10 Ways Local Governments in Multicultural Urban Settings can Support Vaccine Equity in Pandemics. SSHAP, 2022. http://dx.doi.org/10.19088/sshap.2022.016.

Full text
Abstract:
At national and aggregate levels, COVID-19 vaccination across G7 countries appears successful. To date, 79.4% of the total population of G7 countries have received a first dose, 72.9% a second, and 45.4% a booster shot (28th April 2022 data). In France, 80.6% of the total population has had a first dose, 78.2 % have had two doses, and 55.4% have had their booster jabs (28th of April 2022 data). In the UK, 79.3% of the total population has received one dose, 74.1% a second one, and 58.5% have received a booster. In Italy, 85.2% of the total population has had a first dose, 80.4% have had two do
APA, Harvard, Vancouver, ISO, and other styles
3

Juni, Peter, Ashleigh R. Tuite, Issac I. Bogoch, et al. Rollout Strategy for the Pfizer-BioNTech COVID-19 Vaccine in Ontario. Ontario COVID-19 Science Advisory Table, 2021. http://dx.doi.org/10.47326/ocsat.2021.02.06.1.0.

Full text
Abstract:
Administering Pfizer-BioNTech’s COVID-19 vaccine during the early stage of the vaccine rollout (January/February 2021) to as many individuals as possible would prevent more COVID-19 cases in Ontario as compared to reserving half of the initial allotments as second booster doses (Figure 1). On-label use of the vaccine with the administration of two doses is important, as the second dose significantly boosts the immune response and results in a substantial increase in neutralizing antibodies. However, using 100% of the initial allotments immediately to vaccinate as many individuals as possible d
APA, Harvard, Vancouver, ISO, and other styles
4

Curtis, Helen, and The OpenSAFELY Collaborative. OpenSAFELY Vaccine Coverage Report - Third/Booster Doses. OpenSAFELY, 2021. http://dx.doi.org/10.53764/rpt.e780b8d9d0.

Full text
Abstract:
Weekly* report on COVID-19 vaccination coverage in England focussing on THIRD/booster doses which are due, based on the booster dose schedule (6 months since second dose). * please note, updates will occur most weeks but not all.
APA, Harvard, Vancouver, ISO, and other styles
5

Xu, Junjie, Jiaye Liu, Xinquan Lan, Moxin Song, Liangyuan Zhang, and Jiaqi Zhang. Efficacy of the third dose of COVID-19 vaccine: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0114.

Full text
Abstract:
Review question / Objective: To investigate the immune response and related clinical outcomes of healthy adults who received coronavirus vaccine booster compared with those who did not receive the vaccine booster. Condition being studied: The COVID-19 pandemic, which has spread since 2019, has created a huge disease and economic burden on the world. A large number of clinical trials have verified the effectiveness of COVID-19 vaccine. Previous studies have found that the serum conversion rate and antibody level of those vaccinated after the first two doses of COVID-19 vaccine continue to decre
APA, Harvard, Vancouver, ISO, and other styles
6

Vallerani, Sara, Elizabeth Storer, and Costanza Torre. Key Considerations: Equitable Engagement to Promote COVID-19 Vaccine Uptake among Undocumented Urban Migrants. SSHAP, 2022. http://dx.doi.org/10.19088/sshap.2022.013.

Full text
Abstract:
This brief sets out key considerations linked to the promotion of COVID-19 vaccine uptake among undocumented migrants residing in Rome, Italy. We focus on strategies to equitably distribute COVID-19 vaccines. Evidence from Italy is applicable to other contexts where vaccine administration is tied to “vaccine passports” or “immunity passes”. Undocumented migrants have been considered as some of the “hardest to reach” groups to engage in COVID-19 vaccination outreach. This brief uses the term undocumented migrant or migrant for brevity, but we refer to people living without formal Italian citize
APA, Harvard, Vancouver, ISO, and other styles
7

Nahas, Kamal. The Origins of Adjuvants. Asimov Press, 2025. https://doi.org/10.62211/83kj-77hg.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gershoni, Jonathan M., David E. Swayne, Tal Pupko, et al. Discovery and reconstitution of cross-reactive vaccine targets for H5 and H9 avian influenza. United States Department of Agriculture, 2015. http://dx.doi.org/10.32747/2015.7699854.bard.

Full text
Abstract:
Research objectives: Identification of highly conserved B-cell epitopes common to either H5 or H9 subtypes of AI Reconstruction of conserved epitopes from (1) as recombinantimmunogens, and testing their suitability to be used as universal vaccine components by measuring their binding to Influenza vaccinated sera of birds Vaccination of chickens with reconstituted epitopes and evaluation of successful vaccination, clinical protection and viral replication Development of a platform to investigate the dynamics of immune response towards infection or an epitope based vaccine Estimate our ability t
APA, Harvard, Vancouver, ISO, and other styles
9

Busso, Matías, Julian P. Cristia, and Sarah D. Humpage. Research Insights: Can Reminders Boost Vaccination Rates? Inter-American Development Bank, 2019. http://dx.doi.org/10.18235/0001935.

Full text
Abstract:
While families in rural Guatemala recognize the value of vaccination and mostly vaccinate their children at early ages, they often fail to follow through with the course of treatment, drastically reducing the probability of immunization. To encourage members of underserved communities to complete the vaccination cycle, community health workers were given monthly lists of children due for vaccination at the clinic, enabling them to send timely reminders to families. Reminders increased the likelihood that children completed their vaccination treatment by 2.2 percentage points in the treatment c
APA, Harvard, Vancouver, ISO, and other styles
10

Ármás, Julianna, and Ferenc Németh. The Western Balkans Two Years into the Pandemic: Challenges and Opportunities. Külügyi és Külgazdasági Intézet, 2022. http://dx.doi.org/10.47683/kkielemzesek.ke-2022.22.

Full text
Abstract:
As the COVID-19 pandemic continues to define political discourses in the Western Balkans, the economic consequences are becoming more visible. The race for vaccines, combined with a relatively low level of vaccinated population, and the first signs of a looming global economic crisis (i.e. high energy prices and inflation) create tremendous challenges for the entire region. In the meantime, the phenomena of nearshoring (and reshoring) can partially and potentially mitigate the negative (economic) impacts of the pandemic and create new chances for economic growth. The EU must embrace this windo
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Booster Vaccines' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography